Possible Viral Zoonoses in Xenotransplantation

Abstract

Pig‐to‐human xenotransplantation has been proposed as a possible solution to the world shortage of organ donors. Additionally, cell/tissue xenotransplantation shows promise in the treatment of patients with diabetes, neuronal and eye diseases. At present, barriers to xenotransplantation still include graft rejection, physiological compatibility issues and the threat posed by zoonoses. In this article, the current information from recent publications in the field of porcine zoonoses and xenotransplantation is presented. Pathogens of concern including herpesviruses, endogenous retroviruses and hepatitis E virus are known and risk reduction measures against these in xenotranplantation settings are described. Unidentified pathogens pose a separate risk that may not be identified until clinical trials take place and risks vary depending on the diseases, operation practices and graft production processes including geographical factors. Currently, a number of clinical trials are underway using encapsulated porcine islets, which may alter the perceived risks of pathogen transfer.

Key Concepts:

  • Prevention of pathogen transfer in xenotransplantation.

  • The risk of porcine zoonoses is one that should be minimised before xenotransplantation is carried out in human trials.

  • The use of techniques such as encapsulation in cellular xenotransplantation could be used to potentially protect against pathogen transfer.

  • Donor animals used in xenotransplantation should come from specific pathogen‐free herds which have been screened and tested negative for known and potentially zoonotic viruses, such as Swine influenza, hepatitis E, porcine cytomegalovirus and porcine lymphotropic viruses.

  • Porcine endogenous retroviruses cannot be eliminated from donor herds and although their zoonotic potential remains unknown, steps should be taken to minimise the possibility of zoonoses by selecting donor pigs with low PERV copy number and absence of known dangerous PERV subtype and loci.

  • The possibility of unknown zoonotic viruses emerging poses a constant threat. To counteract this a high surveillance and investigatory approach is required, using the most advanced molecular techniques available.

Keywords: xenotransplantation; zoonosis; virus; PERV; herpesvirus; unknown viruses; safety

Figure 1.

Potential porcine cellular and tissue xenotransplant applications. Image used with permission from Microsoft. © Microsoft.

close

References

Baylis SA, Hanschmann KM, Blumel J and Nubling CM (2011) Standardization of hepatitis E virus (HEV) nucleic acid amplification technique‐based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. Journal of Clinical Microbiology 49: 1234–1239.

Beach NM, Córdoba L, Kenney SP and Meng XJ (2011) Productive infection of human hepatolcellular carcinoma cells by porcine circovirus type 1. Vaccine 29: 7303–7306.

Bochkov YA, Palmenberg AC, Lee WM et al. (2011) Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nature Medicine 17: 627–632.

Burbelo PD, Ragheb JA, Kapoor A and Zhang Y (2013) The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2. Biologicals 41: 430–434.

Busby S-A, Crossan C, Godwin J et al. (2013) Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation. Xenotransplantation 20: 188–192.

Charrel RN and de Lamballerie X (2009) Zoonotic aspects of arenavirus infections. Veterinary Microbiology 140: 213–220.

Cheung AK, Wu G, Wang D et al. (2010) Identification and molecular cloning of a novel porcine parvovirus. Archives of Virology 155: 801–806.

Choi HJ, Kim MK, Lee HJ et al. (2011) Efficacy of pig‐to‐rhesus lamellar corneal xenotransplantation. Investigative Ophthalmology & Visual Science 52: 6643–6650.

Cooper DK and Ayares D (2010) The immense potential of xenotransplantation in surgery. International Journal of Surgery 9: 122–129.

Cooper DK, Dorling A, Pierson RN 3rd et al. (2007) Alpha1,3‐galactosyltransferase gene‐knockout pigs for xenotransplantation: where do we go from here? Transplantation 84: 1–7.

Crisci E, Mussa T, Fraile L and Montoya M (2013) Review: influenza virus in pigs. Molecular Immunology 55: 200–211.

Csagola A, Lorincz M, Cadar D et al. (2012) Detection, prevalence and analysis of emerging porcine parvovirus infections. Archives of Virology 157: 1003–1010.

Denner J (2008) Is porcine endogenous retrovirus (PERV) transmission still relevant? Transplantation Proceedings 40: 587–589.

Dorrschuck E, Fischer N, Bravo IG et al. (2011) Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases. Journal of Virology 85: 3842–3857.

Dufkova L, Scigalkova I, Moutelikova R, Malenovska H and Prodelalova J (2012) Genetic diversity of porcine sapoviruses, kobuviruses, and astroviruses in asymptomatic pigs: an emerging new sapovirus GIII genotype. Archives of Virology 158: 549–558.

Dufrane D, Goebbels RM and Gianello P (2010) Alginate macroencapsulation of pig islets allows correction of streptozotocin‐induced diabetes in primates up to 6 months without immunosuppression. Transplantation 90: 1054–1062.

Ekser B, Ezzelarab M, Hara H et al. (2011) Clinical xenotransplantation: the next medical revolution? Lancet 379: 672–683.

Elliott RB (2011) Towards xenotransplantation of pig islets in the clinic. Current Opinion in Organ Transplantation 16: 195–200.

Escaffre O, Borisevich V and Rockx B (2013) Pathogenesis of Hendra and Nipah virus infection in humans. Journal of Infection in Developing Countries 7: 308–311.

Fishman JA, Scobie L and Takeuchi Y (2012) Xenotransplantation‐associated infectious risk: a WHO consultation. Xenotransplantation 19: 72–81.

Garcia‐Alvarez M, Berenguer J, Alvarez E et al. (2012) Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus. European Journal of Clinical Microbiology & Infectious Diseases 32: 289–297.

Garkavenko O, Dieckhoff B, Wynyard S et al. (2008) Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. Journal of Medical Virology 80: 2046–2052.

Ghosh S and Kobayashi N (2011) Whole genome analysis of rotavirus strains: current sstaus and future prospects. Future Microbiology 6: 1049–1065.

Gifford WD, Pfaff SL and Macfarlan TS (2013) Transposable elements as genetic regulatory substrates in early development. Trends in Cell Biology 23: 218–226.

Hara H and Cooper DK (2010) The immunology of corneal xenotransplantation: a review of the literature. Xenotransplantation 17: 338–349.

Huang CA, Fuchimoto Y, Gleit ZL et al. (2001) Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus. Blood 97: 1467–1473.

Issa NC, Wilkinson RA, Griesemer A et al. (2008) Absence of replication of porcine endogenous retrovirus and porcine lymphotropic herpesvirus type 1 with prolonged pig cell microchimerism after pig‐to‐baboon xenotransplantation. Journal of Virology 82: 12441–12448.

Jonsson SR, LaRue RS, Stenglein MD et al. (2007) The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS One 2: e893.

Kamar N, Izopet J and Rostaing L (2013) Hepatitis E virus infection. Current Opinion in Gastroenterology 29: 271–278.

Klymiuk N, Aigner B, Brem G and Wolf E (2009) Genetic modification of pigs as organ donors for xenotransplantation. Molecular Reproduction and Development 77: 209–221.

Lau SK, Woo PC, Tse H et al. (2008) Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. Journal of General Virology 89: 1840–1848.

Leveque X, Nerriere‐Daguin V, Neveu I and Naveilhan P (2012) Pig neural cells derived from foetal mesencephalon as cell source for intracerebral xenotransplantation. Methods in Molecular Biology 885: 233–243.

Lima‐Quaresma KR, Bonavita AG, Cytrangulo MK, Pinto MA and Alves LA (2012) Hepatocyte xenotransplantation. Methods in Molecular Biology 885: 245–249.

Luo K, Liang W, He H et al. (2000) Experimental infection of nonenveloped DNA virus (TTV) in rhesus monkey. Journal of Medical Virology 61: 159–164.

Marigliano M, Bertera S, Grupillo M, Trucco M and Bottino R (2011) Pig‐to‐nonhuman primates pancreatic islet xenotransplantation: an overview. Current Diabetes Reports 11: 402–412.

Martella V, Banyai K, Matthijnssens J, Buonavoglia C and Ciarlet M (2009) Zoonotic aspects of rotaviruses. Veterinary Microbiology 140: 246–255.

Matthijnssens J, Ciarlet M, McDonald SM et al. (2011) Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Archives of Virology 156: 1397–1413.

Mattiuzzo G, Matouskova M and Takeuchi Y (2007) Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Retrovirology 4: 93.

Mattiuzzo G and Takeuchi Y (2010) Suboptimal porcine endogenous retrovirus infection in non‐human primate cells: implication for preclinical xenotransplantation. PLoS One 5: e13203.

Mueller NJ, Ezzelarab M, Buhler L et al. (2009) Monitoring of porcine and baboon cytomegalovirus infection in xenotransplantation. Xenotransplantation 16: 535–536.

Mueller NJ, Kuwaki K, Dor FJ et al. (2004a) Reduction of consumptive coagulopathy using porcine cytomegalovirus‐free cardiac porcine grafts in pig‐to‐primate xenotransplantation. Transplantation 78: 1449–1453.

Mueller NJ, Livingston C, Knosalla C et al. (2004b) Activation of porcine cytomegalovirus, but not porcine lymphotropic herpesvirus, in pig‐to‐baboon xenotransplantation. Journal of Infectious Diseases 189: 1628–1633.

Mueller NJ, Sulling K, Gollackner B et al. (2003) Reduced efficacy of ganciclovir against porcine and baboon cytomegalovirus in pig‐to‐baboon xenotransplantation. American Journal of Transplantation 3: 1057–1064.

Mueller NJ, Takeuchi Y, Mattiuzzo G and Scobie L (2011) Microbial safety in xenotransplantation. Current Opinion in Organ Transplantation 16: 201–206.

Padmanabhan R, Mishra AK, Raoult D and Fournier PE (2013) Genomics and metagenomics in medical microbiology. Journal of Microbiological Methods 95: 415–424.

Palacios G, Druce J, Du L et al. (2008) A new arenavirus in a cluster of fatal transplant‐associated diseases. New England Journal of Medicine 358: 991–998.

Paradis K, Langford G, Long Z et al. (1999) Search for cross‐species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285: 1236–1241.

Reuter G, Boros A and Pankovics P (2011) Kobuvirus – a comprehensive review. Reviews in Medical Virology 21: 32–41.

Rockx B, Winegar R and Freiberg AN (2012) Recent progress in henipavirus research: molecular biology, genetic diversity, animal models. Antiviral Research 95: 135–149.

Salles MW, Scholes SF, Dauber M et al. (2011) Porcine teschovirus polioencephalomyelitis in western Canada. Journal of Veterinary Diagnostic Investigation 23: 367–373.

Santoni F, Lindner I, Caselli E et al. (2006) Molecular interactions between porcine and human gammaherpesviruses: implications for xenografts? Xenotransplantation 13: 308–317.

Schmelzle M, Schulte Esch J 2nd and Robson SC (2010) Coagulation, platelet activation and thrombosis in xenotransplantation. Current Opinion in Organ Transplantation 15: 212–218.

Scobie L and Dalton HR (2013) Hepatitis E: source and route of infection, clinical manifestations and new developments. Journal of Viral Hepatitis 20: 1–11.

Scobie L, Padler‐Karavani V, Le Bas‐Bernardet S et al. (2013) Long‐term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. Journal of Immunology 191: 2907–2915.

Smits SL and Osterhaus ADME (2013) Virus discovery: one step beyond. Current opinion in Virology 3: e1–e6.

Victoria JG, Wang C, Jones MS et al. (2010) Viral nucleic acids in live‐attenuated vaccines: detection of minority variants and an adventitious virus. Journal of Virology 84: 6033–6040.

Villani V, Sekijimal M, Tasaki M et al. (2013) Porcine CMV infection is associated with early rejection of kidney grafts in a pig‐to‐baboon xenotransplantation model. Xenotransplantation 20: 366.

Wang W, Mo Z, Ye B et al. (2012) A clinical trial of xenotransplantation of neonatal pig islets for diabetic patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36: 1134–1140.

Whitteker JL, Dudani AK and Tackaberry ES (2008) Human fibroblasts are permissive for porcine cytomegalovirus in vitro . Transplantation 86: 155–162.

Wilson CA (2008) Endogenous retroviruses: porcine endogenous retroviruses and xenotransplantation. Cellular and Molecular Life Sciences 65: 3399–3412.

Zeng S, Wang D, Fang L et al. (2011) Complete coding sequences and phylogenetic analysis of porcine bocavirus. Journal of General Virology 92: 784–788.

Further Reading

Vanderpool HY (2009) The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes–chapter 7: informed consent and xenotransplantation clinical trials. Xenotransplantation 16(4): 255–262. doi: 10.1111/j.1399‐3089.2009.00546.x.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Crossan, Claire, Takeuchi, Yasu, and Scobie, Linda(May 2014) Possible Viral Zoonoses in Xenotransplantation. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0020708.pub2]